Directed disruption of IL2 aggregation and receptor binding sites produces designer biologics with enhanced specificity and improved production capacity - Amy Dashwood; Ntombizodwa Makuyana; Rob van der Kant; Arman Ghodsinia; Alvaro R. Hernandez; Stephanie Lienart; Oliver Burton; James Dooley; Magda Ali; Lubna Kouser; Francisco Naranjo; Matthew G. Holt; et al. (Computational and Structural Biotechnology Journal, 2025)